nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A2—Organic cation transport—SLC22A4—Crohn's disease	0.0247	0.0703	CbGpPWpGaD
Amantadine—SLC22A2—Organic cation transport—SLC22A5—Crohn's disease	0.0247	0.0703	CbGpPWpGaD
Amantadine—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.023	0.0655	CbGpPWpGaD
Amantadine—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.023	0.0655	CbGpPWpGaD
Amantadine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0167	0.0477	CbGpPWpGaD
Amantadine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0167	0.0477	CbGpPWpGaD
Amantadine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0156	0.0444	CbGpPWpGaD
Amantadine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0156	0.0444	CbGpPWpGaD
Amantadine—DDC—Parkinsons Disease Pathway—LRRK2—Crohn's disease	0.0155	0.0441	CbGpPWpGaD
Amantadine—Delirium—Mesalazine—Crohn's disease	0.0122	0.0187	CcSEcCtD
Amantadine—Leukocytosis—Mesalazine—Crohn's disease	0.0111	0.0172	CcSEcCtD
Amantadine—Coma—Mesalazine—Crohn's disease	0.00956	0.0147	CcSEcCtD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00935	0.0266	CbGpPWpGaD
Amantadine—Hypertonia—Mesalazine—Crohn's disease	0.00917	0.0141	CcSEcCtD
Amantadine—Photosensitivity—Mesalazine—Crohn's disease	0.00865	0.0133	CcSEcCtD
Amantadine—Alopecia—Mercaptopurine—Crohn's disease	0.00855	0.0132	CcSEcCtD
Amantadine—Disorientation—Mesalazine—Crohn's disease	0.00849	0.0131	CcSEcCtD
Amantadine—Eczema—Mesalazine—Crohn's disease	0.00845	0.013	CcSEcCtD
Amantadine—Malnutrition—Mercaptopurine—Crohn's disease	0.00843	0.013	CcSEcCtD
Amantadine—Renal failure acute—Mesalazine—Crohn's disease	0.00822	0.0127	CcSEcCtD
Amantadine—Libido decreased—Mesalazine—Crohn's disease	0.00819	0.0126	CcSEcCtD
Amantadine—Suicidal ideation—Prednisone—Crohn's disease	0.00789	0.0122	CcSEcCtD
Amantadine—Delusion—Prednisone—Crohn's disease	0.00782	0.0121	CcSEcCtD
Amantadine—Lethargy—Mesalazine—Crohn's disease	0.00775	0.0119	CcSEcCtD
Amantadine—Mania—Prednisone—Crohn's disease	0.00761	0.0117	CcSEcCtD
Amantadine—Osteoarthritis—Mesalazine—Crohn's disease	0.00759	0.0117	CcSEcCtD
Amantadine—Leukopenia—Mercaptopurine—Crohn's disease	0.00754	0.0116	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00753	0.0116	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—KSR1—Crohn's disease	0.0073	0.0208	CbGpPWpGaD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00712	0.011	CcSEcCtD
Amantadine—GRIN2B—BDNF signaling pathway—KSR1—Crohn's disease	0.00712	0.0203	CbGpPWpGaD
Amantadine—Liver function test abnormal—Mesalazine—Crohn's disease	0.00701	0.0108	CcSEcCtD
Amantadine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00693	0.0107	CcSEcCtD
Amantadine—Oedema—Mercaptopurine—Crohn's disease	0.00688	0.0106	CcSEcCtD
Amantadine—Skin disorder—Mercaptopurine—Crohn's disease	0.00668	0.0103	CcSEcCtD
Amantadine—Dysphagia—Mesalazine—Crohn's disease	0.00656	0.0101	CcSEcCtD
Amantadine—Anorexia—Mercaptopurine—Crohn's disease	0.00655	0.0101	CcSEcCtD
Amantadine—Delirium—Prednisone—Crohn's disease	0.00643	0.00992	CcSEcCtD
Amantadine—Neutropenia—Mesalazine—Crohn's disease	0.00614	0.00946	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.00604	0.0172	CbGpPWpGaD
Amantadine—Agranulocytosis—Azathioprine—Crohn's disease	0.00599	0.00924	CcSEcCtD
Amantadine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00599	0.00923	CcSEcCtD
Amantadine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00598	0.00921	CcSEcCtD
Amantadine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00594	0.00915	CcSEcCtD
Amantadine—Leukocytosis—Prednisone—Crohn's disease	0.00589	0.00908	CcSEcCtD
Amantadine—Agranulocytosis—Mesalazine—Crohn's disease	0.00546	0.00842	CcSEcCtD
Amantadine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00544	0.00838	CcSEcCtD
Amantadine—Mediastinal disorder—Azathioprine—Crohn's disease	0.0052	0.00801	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.00519	0.0148	CbGpPWpGaD
Amantadine—Urinary tract disorder—Mesalazine—Crohn's disease	0.00519	0.008	CcSEcCtD
Amantadine—Oedema peripheral—Mesalazine—Crohn's disease	0.00517	0.00798	CcSEcCtD
Amantadine—Arrhythmia—Azathioprine—Crohn's disease	0.00515	0.00794	CcSEcCtD
Amantadine—Urethral disorder—Mesalazine—Crohn's disease	0.00515	0.00794	CcSEcCtD
Amantadine—Alopecia—Azathioprine—Crohn's disease	0.0051	0.00786	CcSEcCtD
Amantadine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00507	0.00781	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—CREM—Crohn's disease	0.00493	0.014	CbGpPWpGaD
Amantadine—Pulmonary oedema—Prednisone—Crohn's disease	0.00493	0.00759	CcSEcCtD
Amantadine—Eye disorder—Mesalazine—Crohn's disease	0.00491	0.00757	CcSEcCtD
Amantadine—Cardiac disorder—Mesalazine—Crohn's disease	0.00487	0.00752	CcSEcCtD
Amantadine—Hyperkinesia—Prednisone—Crohn's disease	0.00483	0.00744	CcSEcCtD
Amantadine—Angiopathy—Mesalazine—Crohn's disease	0.00477	0.00735	CcSEcCtD
Amantadine—Euphoric mood—Prednisone—Crohn's disease	0.00475	0.00733	CcSEcCtD
Amantadine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00473	0.0073	CcSEcCtD
Amantadine—Diarrhoea—Mercaptopurine—Crohn's disease	0.0047	0.00725	CcSEcCtD
Amantadine—Alopecia—Mesalazine—Crohn's disease	0.00464	0.00716	CcSEcCtD
Amantadine—Mental disorder—Mesalazine—Crohn's disease	0.0046	0.00709	CcSEcCtD
Amantadine—Leukopenia—Azathioprine—Crohn's disease	0.00449	0.00693	CcSEcCtD
Amantadine—Tension—Mesalazine—Crohn's disease	0.00449	0.00692	CcSEcCtD
Amantadine—Nervousness—Mesalazine—Crohn's disease	0.00444	0.00685	CcSEcCtD
Amantadine—Cardiac failure congestive—Prednisone—Crohn's disease	0.00443	0.00683	CcSEcCtD
Amantadine—Vomiting—Mercaptopurine—Crohn's disease	0.00437	0.00674	CcSEcCtD
Amantadine—Rash—Mercaptopurine—Crohn's disease	0.00434	0.00668	CcSEcCtD
Amantadine—Dermatitis—Mercaptopurine—Crohn's disease	0.00433	0.00668	CcSEcCtD
Amantadine—Vision blurred—Mesalazine—Crohn's disease	0.00431	0.00664	CcSEcCtD
Amantadine—Tremor—Mesalazine—Crohn's disease	0.00428	0.0066	CcSEcCtD
Amantadine—Amnesia—Prednisone—Crohn's disease	0.00428	0.00659	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00424	0.00654	CcSEcCtD
Amantadine—Cardiac failure—Prednisone—Crohn's disease	0.00412	0.00635	CcSEcCtD
Amantadine—Lethargy—Prednisone—Crohn's disease	0.0041	0.00632	CcSEcCtD
Amantadine—Leukopenia—Mesalazine—Crohn's disease	0.00409	0.00631	CcSEcCtD
Amantadine—Nausea—Mercaptopurine—Crohn's disease	0.00408	0.0063	CcSEcCtD
Amantadine—Palpitations—Mesalazine—Crohn's disease	0.00404	0.00623	CcSEcCtD
Amantadine—Osteoarthritis—Prednisone—Crohn's disease	0.00402	0.00619	CcSEcCtD
Amantadine—Skin disorder—Azathioprine—Crohn's disease	0.00398	0.00613	CcSEcCtD
Amantadine—Hypertension—Mesalazine—Crohn's disease	0.00395	0.00609	CcSEcCtD
Amantadine—Psychotic disorder—Prednisone—Crohn's disease	0.00392	0.00605	CcSEcCtD
Amantadine—Anxiety—Mesalazine—Crohn's disease	0.00388	0.00598	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00387	0.00596	CcSEcCtD
Amantadine—Irritability—Prednisone—Crohn's disease	0.00383	0.00591	CcSEcCtD
Amantadine—Hypotension—Azathioprine—Crohn's disease	0.00383	0.0059	CcSEcCtD
Amantadine—Cardiac arrest—Prednisone—Crohn's disease	0.00382	0.00589	CcSEcCtD
Amantadine—Dry mouth—Mesalazine—Crohn's disease	0.00381	0.00587	CcSEcCtD
Amantadine—Confusional state—Mesalazine—Crohn's disease	0.00376	0.0058	CcSEcCtD
Amantadine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00373	0.00575	CcSEcCtD
Amantadine—Oedema—Mesalazine—Crohn's disease	0.00373	0.00575	CcSEcCtD
Amantadine—Nervous system disorder—Mesalazine—Crohn's disease	0.00366	0.00564	CcSEcCtD
Amantadine—Tachycardia—Mesalazine—Crohn's disease	0.00364	0.00561	CcSEcCtD
Amantadine—Skin disorder—Mesalazine—Crohn's disease	0.00362	0.00559	CcSEcCtD
Amantadine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00361	0.00556	CcSEcCtD
Amantadine—Anorexia—Mesalazine—Crohn's disease	0.00356	0.00548	CcSEcCtD
Amantadine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00354	0.00545	CcSEcCtD
Amantadine—Hypotension—Mesalazine—Crohn's disease	0.00349	0.00538	CcSEcCtD
Amantadine—Sweating increased—Prednisone—Crohn's disease	0.00338	0.00521	CcSEcCtD
Amantadine—Feeling abnormal—Azathioprine—Crohn's disease	0.00338	0.0052	CcSEcCtD
Amantadine—Insomnia—Mesalazine—Crohn's disease	0.00338	0.0052	CcSEcCtD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00335	0.00955	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00335	0.00955	CbGpPWpGaD
Amantadine—Paraesthesia—Mesalazine—Crohn's disease	0.00335	0.00517	CcSEcCtD
Amantadine—Dyspnoea—Mesalazine—Crohn's disease	0.00333	0.00513	CcSEcCtD
Amantadine—Somnolence—Mesalazine—Crohn's disease	0.00332	0.00511	CcSEcCtD
Amantadine—Dyspepsia—Mesalazine—Crohn's disease	0.00328	0.00506	CcSEcCtD
Amantadine—Neutropenia—Prednisone—Crohn's disease	0.00325	0.00501	CcSEcCtD
Amantadine—Decreased appetite—Mesalazine—Crohn's disease	0.00324	0.005	CcSEcCtD
Amantadine—Body temperature increased—Azathioprine—Crohn's disease	0.00324	0.00499	CcSEcCtD
Amantadine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00322	0.00497	CcSEcCtD
Amantadine—Fatigue—Mesalazine—Crohn's disease	0.00322	0.00496	CcSEcCtD
Amantadine—Constipation—Mesalazine—Crohn's disease	0.00319	0.00492	CcSEcCtD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00313	0.0089	CbGpPWpGaD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00313	0.0089	CbGpPWpGaD
Amantadine—Feeling abnormal—Mesalazine—Crohn's disease	0.00308	0.00474	CcSEcCtD
Amantadine—Hypersensitivity—Azathioprine—Crohn's disease	0.00302	0.00465	CcSEcCtD
Amantadine—GRIN2B—ErbB4 signaling events—JAK2—Crohn's disease	0.00296	0.00844	CbGpPWpGaD
Amantadine—Body temperature increased—Mesalazine—Crohn's disease	0.00295	0.00455	CcSEcCtD
Amantadine—DDC—Dopaminergic Neurogenesis—STAT3—Crohn's disease	0.00294	0.00836	CbGpPWpGaD
Amantadine—Diarrhoea—Azathioprine—Crohn's disease	0.0028	0.00432	CcSEcCtD
Amantadine—Hallucination—Prednisone—Crohn's disease	0.00277	0.00426	CcSEcCtD
Amantadine—Hypersensitivity—Mesalazine—Crohn's disease	0.00275	0.00424	CcSEcCtD
Amantadine—Dizziness—Azathioprine—Crohn's disease	0.00271	0.00418	CcSEcCtD
Amantadine—Asthenia—Mesalazine—Crohn's disease	0.00268	0.00413	CcSEcCtD
Amantadine—Pruritus—Mesalazine—Crohn's disease	0.00264	0.00407	CcSEcCtD
Amantadine—Vomiting—Azathioprine—Crohn's disease	0.0026	0.00402	CcSEcCtD
Amantadine—Eye disorder—Prednisone—Crohn's disease	0.0026	0.004	CcSEcCtD
Amantadine—Rash—Azathioprine—Crohn's disease	0.00258	0.00398	CcSEcCtD
Amantadine—Dermatitis—Azathioprine—Crohn's disease	0.00258	0.00398	CcSEcCtD
Amantadine—Headache—Azathioprine—Crohn's disease	0.00257	0.00396	CcSEcCtD
Amantadine—Diarrhoea—Mesalazine—Crohn's disease	0.00255	0.00394	CcSEcCtD
Amantadine—Angiopathy—Prednisone—Crohn's disease	0.00252	0.00389	CcSEcCtD
Amantadine—Arrhythmia—Prednisone—Crohn's disease	0.00248	0.00383	CcSEcCtD
Amantadine—Dizziness—Mesalazine—Crohn's disease	0.00247	0.0038	CcSEcCtD
Amantadine—Alopecia—Prednisone—Crohn's disease	0.00246	0.00379	CcSEcCtD
Amantadine—Mental disorder—Prednisone—Crohn's disease	0.00243	0.00375	CcSEcCtD
Amantadine—Nausea—Azathioprine—Crohn's disease	0.00243	0.00375	CcSEcCtD
Amantadine—Malnutrition—Prednisone—Crohn's disease	0.00242	0.00373	CcSEcCtD
Amantadine—Vomiting—Mesalazine—Crohn's disease	0.00237	0.00366	CcSEcCtD
Amantadine—Rash—Mesalazine—Crohn's disease	0.00235	0.00363	CcSEcCtD
Amantadine—Dermatitis—Mesalazine—Crohn's disease	0.00235	0.00362	CcSEcCtD
Amantadine—Headache—Mesalazine—Crohn's disease	0.00234	0.0036	CcSEcCtD
Amantadine—Vision blurred—Prednisone—Crohn's disease	0.00228	0.00351	CcSEcCtD
Amantadine—Agitation—Prednisone—Crohn's disease	0.00222	0.00343	CcSEcCtD
Amantadine—Nausea—Mesalazine—Crohn's disease	0.00222	0.00342	CcSEcCtD
Amantadine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.0021	0.00599	CbGpPWpGaD
Amantadine—Convulsion—Prednisone—Crohn's disease	0.0021	0.00323	CcSEcCtD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00209	0.00595	CbGpPWpGaD
Amantadine—Hypertension—Prednisone—Crohn's disease	0.00209	0.00322	CcSEcCtD
Amantadine—GRIN2C—Alzheimers Disease—IL1B—Crohn's disease	0.00208	0.00593	CbGpPWpGaD
Amantadine—Anxiety—Prednisone—Crohn's disease	0.00205	0.00316	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00205	0.00315	CcSEcCtD
Amantadine—Oedema—Prednisone—Crohn's disease	0.00197	0.00304	CcSEcCtD
Amantadine—Anaphylactic shock—Prednisone—Crohn's disease	0.00197	0.00304	CcSEcCtD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00195	0.00554	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—CREM—Crohn's disease	0.00194	0.00553	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—IL1B—Crohn's disease	0.00194	0.00552	CbGpPWpGaD
Amantadine—Nervous system disorder—Prednisone—Crohn's disease	0.00194	0.00299	CcSEcCtD
Amantadine—Tachycardia—Prednisone—Crohn's disease	0.00193	0.00297	CcSEcCtD
Amantadine—Skin disorder—Prednisone—Crohn's disease	0.00192	0.00296	CcSEcCtD
Amantadine—Hyperhidrosis—Prednisone—Crohn's disease	0.00191	0.00294	CcSEcCtD
Amantadine—Anorexia—Prednisone—Crohn's disease	0.00188	0.0029	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00184	0.00523	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00179	0.00509	CbGpPWpGaD
Amantadine—Insomnia—Prednisone—Crohn's disease	0.00179	0.00275	CcSEcCtD
Amantadine—Paraesthesia—Prednisone—Crohn's disease	0.00177	0.00273	CcSEcCtD
Amantadine—Dyspepsia—Prednisone—Crohn's disease	0.00174	0.00268	CcSEcCtD
Amantadine—Decreased appetite—Prednisone—Crohn's disease	0.00172	0.00265	CcSEcCtD
Amantadine—Fatigue—Prednisone—Crohn's disease	0.0017	0.00262	CcSEcCtD
Amantadine—Constipation—Prednisone—Crohn's disease	0.00169	0.0026	CcSEcCtD
Amantadine—Feeling abnormal—Prednisone—Crohn's disease	0.00163	0.00251	CcSEcCtD
Amantadine—GRIN2A—Alzheimers Disease—IL1B—Crohn's disease	0.00159	0.00453	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00157	0.00448	CbGpPWpGaD
Amantadine—Body temperature increased—Prednisone—Crohn's disease	0.00156	0.00241	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—TLR4—Crohn's disease	0.00155	0.0044	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00154	0.00437	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00152	0.00434	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00152	0.00434	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TNF—Crohn's disease	0.00151	0.00431	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00149	0.00425	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—ICAM1—Crohn's disease	0.00148	0.00422	CbGpPWpGaD
Amantadine—Hypersensitivity—Prednisone—Crohn's disease	0.00145	0.00224	CcSEcCtD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00142	0.00404	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00142	0.00404	CbGpPWpGaD
Amantadine—Asthenia—Prednisone—Crohn's disease	0.00142	0.00218	CcSEcCtD
Amantadine—GRIN2D—Alzheimers Disease—TNF—Crohn's disease	0.00141	0.004	CbGpPWpGaD
Amantadine—Pruritus—Prednisone—Crohn's disease	0.0014	0.00215	CcSEcCtD
Amantadine—GRIN1—Alzheimers Disease—IL1B—Crohn's disease	0.00139	0.00395	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—IL1B—Crohn's disease	0.00135	0.00385	CbGpPWpGaD
Amantadine—Diarrhoea—Prednisone—Crohn's disease	0.00135	0.00208	CcSEcCtD
Amantadine—Dizziness—Prednisone—Crohn's disease	0.00131	0.00201	CcSEcCtD
Amantadine—DRD2—G alpha (i) signalling events—CCR9—Crohn's disease	0.0013	0.0037	CbGpPWpGaD
Amantadine—Vomiting—Prednisone—Crohn's disease	0.00126	0.00194	CcSEcCtD
Amantadine—Rash—Prednisone—Crohn's disease	0.00124	0.00192	CcSEcCtD
Amantadine—Dermatitis—Prednisone—Crohn's disease	0.00124	0.00192	CcSEcCtD
Amantadine—Headache—Prednisone—Crohn's disease	0.00124	0.00191	CcSEcCtD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00121	0.00343	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—ACKR2—Crohn's disease	0.0012	0.00341	CbGpPWpGaD
Amantadine—Nausea—Prednisone—Crohn's disease	0.00117	0.00181	CcSEcCtD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00117	0.00332	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TNF—Crohn's disease	0.00115	0.00329	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—MLN—Crohn's disease	0.00114	0.00323	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IFNG—Crohn's disease	0.00113	0.00321	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00112	0.00319	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.00111	0.00315	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—PTGS2—Crohn's disease	0.00108	0.00308	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00107	0.00306	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CXCL8—Crohn's disease	0.00105	0.00299	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00103	0.00294	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.00103	0.00293	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TNF—Crohn's disease	0.00101	0.00287	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL1B—Crohn's disease	0.00101	0.00287	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.001	0.00285	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TNF—Crohn's disease	0.000982	0.00279	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—JAK2—Crohn's disease	0.000981	0.00279	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000977	0.00278	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000961	0.00274	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—JAK2—Crohn's disease	0.000956	0.00272	CbGpPWpGaD
Amantadine—DDC—Metabolism—PLA2G4F—Crohn's disease	0.000955	0.00272	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000949	0.0027	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000937	0.00267	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000885	0.00252	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—CCR6—Crohn's disease	0.000861	0.00245	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00084	0.00239	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000835	0.00238	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTMR3—Crohn's disease	0.000812	0.00231	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000805	0.00229	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PLA2G4F—Crohn's disease	0.000804	0.00229	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000799	0.00228	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CCR9—Crohn's disease	0.000787	0.00224	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000775	0.0022	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000775	0.0022	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000752	0.00214	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GPR65—Crohn's disease	0.000732	0.00208	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TNF—Crohn's disease	0.000731	0.00208	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000722	0.00206	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000722	0.00206	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—STAT3—Crohn's disease	0.00072	0.00205	CbGpPWpGaD
Amantadine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000704	0.002	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—STAT3—Crohn's disease	0.000702	0.002	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000685	0.00195	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTMR3—Crohn's disease	0.000684	0.00195	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00068	0.00194	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.00067	0.00191	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—MLN—Crohn's disease	0.000642	0.00183	CbGpPWpGaD
Amantadine—DDC—Metabolism—FADS1—Crohn's disease	0.000633	0.0018	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ACKR2—Crohn's disease	0.000615	0.00175	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000603	0.00172	CbGpPWpGaD
Amantadine—DDC—Metabolism—GPX4—Crohn's disease	0.000593	0.00169	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL6—Crohn's disease	0.00059	0.00168	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—SMAD3—Crohn's disease	0.000588	0.00167	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000584	0.00166	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MLN—Crohn's disease	0.000583	0.00166	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—SMAD3—Crohn's disease	0.000573	0.00163	CbGpPWpGaD
Amantadine—DDC—Metabolism—GCKR—Crohn's disease	0.000572	0.00163	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000549	0.00156	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000546	0.00155	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—TYK2—Crohn's disease	0.000537	0.00153	CbGpPWpGaD
Amantadine—MAOB—Metabolism—FADS1—Crohn's disease	0.000533	0.00152	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—TYK2—Crohn's disease	0.000524	0.00149	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CCR6—Crohn's disease	0.000521	0.00148	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—JAK2—Crohn's disease	0.000513	0.00146	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000509	0.00145	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—JAK2—Crohn's disease	0.0005	0.00142	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GPX4—Crohn's disease	0.000499	0.00142	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000482	0.00137	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GCKR—Crohn's disease	0.000482	0.00137	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000472	0.00134	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000472	0.00134	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	0.000459	0.00131	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00045	0.00128	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—IL6—Crohn's disease	0.000448	0.00128	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	0.000445	0.00127	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000442	0.00126	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	0.000427	0.00121	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000423	0.0012	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000423	0.0012	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	0.000414	0.00118	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000411	0.00117	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCR9—Crohn's disease	0.000404	0.00115	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	0.000398	0.00113	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000394	0.00112	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TYK2—Crohn's disease	0.000383	0.00109	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GPR65—Crohn's disease	0.000376	0.00107	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TYK2—Crohn's disease	0.000374	0.00106	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—JAK2—Crohn's disease	0.000366	0.00104	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ACKR2—Crohn's disease	0.000363	0.00103	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTMR3—Crohn's disease	0.000363	0.00103	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—JAK2—Crohn's disease	0.000357	0.00101	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MLN—Crohn's disease	0.000344	0.00098	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000342	0.000973	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTMR3—Crohn's disease	0.000338	0.000963	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000319	0.000907	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TAGAP—Crohn's disease	0.000315	0.000896	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000298	0.000849	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	0.000295	0.000839	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000286	0.000814	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—FADS1—Crohn's disease	0.000283	0.000805	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000278	0.00079	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RSPO3—Crohn's disease	0.000275	0.000783	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—STAT3—Crohn's disease	0.000268	0.000764	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCR6—Crohn's disease	0.000268	0.000762	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GPX4—Crohn's disease	0.000265	0.000753	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000264	0.00075	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—FADS1—Crohn's disease	0.000263	0.00075	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—Crohn's disease	0.000263	0.000748	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—STAT3—Crohn's disease	0.000262	0.000745	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SEL1L—Crohn's disease	0.000261	0.000743	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000259	0.000738	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—Crohn's disease	0.000256	0.000729	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GCKR—Crohn's disease	0.000256	0.000728	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GPX4—Crohn's disease	0.000247	0.000702	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCR9—Crohn's disease	0.000239	0.000679	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCKR—Crohn's disease	0.000238	0.000678	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	0.000236	0.000671	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000233	0.000664	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—Crohn's disease	0.000232	0.000661	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—Crohn's disease	0.000227	0.000645	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GPR65—Crohn's disease	0.000222	0.000632	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—IL3—Crohn's disease	0.000221	0.000629	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000221	0.000628	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000214	0.000608	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000209	0.000595	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL3—Crohn's disease	0.000201	0.000571	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000198	0.000564	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000194	0.000552	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—Crohn's disease	0.000188	0.000534	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—Crohn's disease	0.000183	0.00052	CbGpPWpGaD
Amantadine—DDC—Metabolism—ALB—Crohn's disease	0.000182	0.000518	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—Crohn's disease	0.000177	0.000503	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000174	0.000494	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	0.000168	0.000478	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000162	0.000461	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—Crohn's disease	0.000159	0.000454	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCR6—Crohn's disease	0.000158	0.00045	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000155	0.000441	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FADS1—Crohn's disease	0.000154	0.00044	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—Crohn's disease	0.000153	0.000436	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX4—Crohn's disease	0.000145	0.000412	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RBX1—Crohn's disease	0.000143	0.000407	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000141	0.000402	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	0.000141	0.0004	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCKR—Crohn's disease	0.00014	0.000398	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	0.000139	0.000396	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—Crohn's disease	0.000134	0.000382	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	0.000125	0.000357	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	0.000122	0.000346	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL3—Crohn's disease	0.000119	0.000337	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	0.000115	0.000326	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	0.000104	0.000296	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	0.000104	0.000296	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	9.9e-05	0.000282	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	9.5e-05	0.00027	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	9.49e-05	0.00027	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	9.45e-05	0.000269	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	8.97e-05	0.000255	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	8.62e-05	0.000245	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	8.3e-05	0.000236	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—Crohn's disease	8.14e-05	0.000232	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—Crohn's disease	7.58e-05	0.000216	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—Crohn's disease	7.12e-05	0.000203	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—Crohn's disease	6.63e-05	0.000189	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TYK2—Crohn's disease	5.85e-05	0.000167	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JAK2—Crohn's disease	5.58e-05	0.000159	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	5.09e-05	0.000145	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—Crohn's disease	4.84e-05	0.000138	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—Crohn's disease	4.44e-05	0.000127	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STAT3—Crohn's disease	4.1e-05	0.000117	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—Crohn's disease	3.89e-05	0.000111	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—Crohn's disease	2.86e-05	8.15e-05	CbGpPWpGaD
